Nu-Med Plus issues 500,000 Series A preferred shares in unregistered sale under Regulation S

• Nu-Med Plus issued 500,000 shares of Series A Preferred Stock to MegumaGold in an unregistered sale tied to an asset acquisition.
• No cash proceeds received. No underwriter or placement agent participated.
• Each preferred share votes 20 votes. Each is convertible into 20 common shares, subject to a 4.999% ownership cap.
• Full conversion could yield up to 10,000,000 common shares, excluding beneficial ownership limits.
• Securities were issued under Regulation S. Any U.S. resale would require registration or an exemption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nu-Med Plus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000609), on August 25, 2026, and is solely responsible for the information contained therein.